News Headlines Article

Why $3 Billion Worth of High-Tech Drugs Are Wasted Each Year
The Fiscal Times

The soaring costs of breakthrough biometric drugs — especially for the treatment of the Hepatitis-C virus and cancer – have squeezed budgets across the board—on patients, hospitals, insurers and government healthcare programs.

Yet far less attention has been paid to the sheer waste of those vital and pricey drugs within the U.S. health care system. A new study published Monday by a research team at New York’s Sloan Kettering Cancer Center concluded that nearly $3 billion a year is wasted by purchasing injectable cancer medicine in vials or containers that provide more medicine than is needed by a patient, with the remainder simply thrown away.